Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-x4r87 Total loading time: 0 Render date: 2024-04-28T08:29:01.238Z Has data issue: false hasContentIssue false

Chapter 14 - Sexual Dysfunction in Parkinson’s Disease

Published online by Cambridge University Press:  05 March 2022

By
Gila Bronner  and
Tanya Gurevich
Edited by
Néstor Gálvez-Jiménez ,
Amos D. Korczyn  and
Ramón Lugo-Sanchez
Néstor Gálvez-Jiménez
Affiliation:
Florida International University
Amos D. Korczyn
Affiliation:
Tel-Aviv University
Ramón Lugo-Sanchez
Affiliation:
Cleveland Clinic
Get access

Summary

Parkinson’s disease (PD) is an age-related neurodegenerative multisystem progressive disorder belonging to the α-synucleinopathy spectrum, with well-known and widely reported motor symptoms, such as tremor, rigidity, bradykinesia, and postural instability, and with highly prevalent and previously often neglected non-motor symptoms (NMS) [1], such as pain, depression, anxiety, sleep disturbances, cognitive dysfunction, and many others, that may precede the motor symptoms [2]. Sexual dysfunction (SD) is usually included in the category of autonomic NMS in PD, even though its etiology is multifactorial and involves interaction with other motor and NMS of PD [3–5]. Patients with PD rated SD twelfth out of 24 most bothersome symptoms of their disease [6], but SD remains an underrated non-motor feature of PD despite its high frequency and severe impact on the patient’s quality of life [7, 8].

Type
Chapter
Information
Non-motor Parkinson's Disease , pp. 155 - 166
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Shulman, LM, Taback, RL, Rabinstein, AA, et al. Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Park Relat Disord 2002; 8: 193–197.Google Scholar
Seppi, K, Weintraub, D, Coelho, M, et al. The Movement Disorder Society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson’s disease. Mov Disord 2011; 26: S42–80.CrossRefGoogle ScholarPubMed
Basson, R, Rees, P, Wang, R, et al. Sexual function in chronic illness. J Sex Med 2010; 7 : 374–388.CrossRefGoogle ScholarPubMed
Bronner, G, Aharon-Peretz, J, Hassin-Baer, S. Sexuality in patients with Parkinson’s disease, Alzheimer’s disease, and other dementias. Handb Clin Neurol 2015; 130: 297–323.Google Scholar
Kotková, P, Weiss, P. Psychiatric factors related to sexual functioning in patients with Parkinson’s disease. Clin Neurol Neurosurg 2013; 115: 419–424.CrossRefGoogle ScholarPubMed
Politis, M, Wu, K, Molloy, S, et al. Parkinson’s disease symptoms: the patient’s perspective. Mov Disord 2010; 25: 1646–1651.CrossRefGoogle ScholarPubMed
Bhattacharyya, KB, Rosa-Grilo, M. Sexual dysfunctions in Parkinson’s disease: an underrated problem in a much-discussed disorder. Int Rev Neurobiol 2017; 134: 859–876.Google Scholar
Bronner, G, Royter, V, Korczyn, AD, et al. Sexual dysfunction in Parkinson’s disease. J Sex Marital Ther 2004; 30: 95–105.CrossRefGoogle ScholarPubMed
Gao, X, Chen, H, Schwarzschild, MA, et al. Erectile function and risk of Parkinson’s disease. Am J Epidemiol 2007; 166: 1446–1450.Google Scholar
Buhmann, C, Dogac, S, Vettorazzi, E, et al. The impact of Parkinson’s disease on patients’ sexuality and relationship. J Neural Transm 2017; 128: 983–996.CrossRefGoogle Scholar
Palma, JA, Kaufmann, H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord 2018; 33: 372–390.CrossRefGoogle ScholarPubMed
Kummer, A, Cardoso, F, Teixeira, AL. Loss of libido in Parkinson’s disease. J Sex Med 2009; 6: 1024–1031.CrossRefGoogle ScholarPubMed
Wermuth, L, Stenager, E. Sexual aspects of Parkinson’s disease. Semin Neurol 1992; 12: 125–127.CrossRefGoogle ScholarPubMed
Brown, RG, Jahanshahi, M, Quinn, N, et al. Sexual function in patients with Parkinson’s disease and their partners. J Neurol Neurosurg Psychiatry 1990; 53: 480–486.Google Scholar
Bronner, G, Israeli-Korn, S, Hassin-Baer, S, et al. Acquired premature ejaculation in Parkinson’s disease and possible mechanisms. Int J Impot Res 2018; 30: 153–157.CrossRefGoogle ScholarPubMed
Bronner, G, Hassin-Baer, S, Gurevich, T. Sexual preoccupation behavior in Parkinson’s disease. J Parkinsons Dis 2017; 7: 175–182.Google Scholar
Coon, EA, Cutsforth-Gregory, JK, Benarroch, EE. Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord 2018; 33: 349–358.CrossRefGoogle ScholarPubMed
Wakabayashi, K, Takahashi, H. Neuropathology of autonomic nervous system in Parkinson’s disease. Eur Neurol 1997; 38(Suppl 2): 2–7.CrossRefGoogle ScholarPubMed
Garrido, A, Aldecoa, I, Gelpi, E, et al. Aggregation of alpha synuclein in the gonadal tissue of two patients with Parkinson disease. JAMA Neurol 2017; 74: 606–607.CrossRefGoogle Scholar
Ikemoto, S, Yang, C, Tan, A. Basal ganglia circuit loops, dopamine and motivation: a review and enquiry. Behav Brain Res 2015; 290: 17–31.CrossRefGoogle ScholarPubMed
Basson, R. Human sexual response. Handb Clin Neurol 2015; 130: 11–18.Google Scholar
Beier, KM, Luders, M, Boxdorfer, SA. Sexuality and partnership aspects of Parkinson’s disease: results of an empirical study of patients and their partners. Fortschr Neurol Psychiatr 2000; 68: 564–575.Google Scholar
Ambler, N, Williams, AC, Hill, P, et al. Sexual difficulties of chronic pain patients. Clin J Pain 2001; 17 :138–145.CrossRefGoogle ScholarPubMed
Berman, JR, Adhikari, SP, Goldstein, I. Anatomy and physiology of female sexual function and dysfunction: classification, evaluation, and treatment options. Eur Urol 2000; 38: 20–29.CrossRefGoogle ScholarPubMed
Koller, WC, Vetere-Overfield, B, Williamson, A, et al. Sexual dysfunction in Parkinson’s disease. Clin Neuropharmacol 1990; 13: 461–463.Google Scholar
Varanda, S, Ribeiro da Silva, J, Costa, AS, et al. Sexual dysfunction in women with Parkinson’s disease. Mov Disord 2016; 31: 1685–1693.Google Scholar
Posen, J, Moore, O, Tassa, DS, et al. Young women with PD: a group work experience. Soc Work Health Care 2000; 32: 77–91.Google Scholar
Schartau, E, Tolson, D, Fleming, V. Parkinson’s disease: the effects on womanhood. Nurs Stand 2003; 17: 33–39.Google Scholar
Thomtén, J, Lundahl, R, Stigenberg, K, et al. Fear avoidance and pain catastrophizing among women with sexual pain. Womens Health 2014; 10: 571–581.Google Scholar
Lerman, SF, Bronner, G, Cohen, OS, et al. Catastrophizing mediates the relationship between non-motor symptoms and quality of life in Parkinson’s disease. Disabil Health J 2019; 12: 673–678.Google Scholar
Rubin, SM. Parkinson’s disease in women. Dis Mon 2007; 53: 206–213.Google Scholar
Hand, A, Gray, WK, Chandler, BJ, et al. Sexual and relationship dysfunction in people with Parkinson’s disease. Parkinsonism Relat Disord 2010; 16: 172–176.CrossRefGoogle ScholarPubMed
Bronner, G, Cohen, OS, Yahalom, G, et al. Correlates of quality of sexual life in male and female patients with Parkinson disease and their partners. Parkinsonism Relat Disord 2014; 20(10): 1085–1088.CrossRefGoogle ScholarPubMed
Raffaele, R, Vecchio, I, Giammusso, B, et al. Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson’s disease. Eur Urol 2002; 41: 382–386.Google Scholar
Safarinejad, MR, Taghva, A, Shekarchi, B, et al. Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: a double-blind, placebo-controlled, randomized study. Int J Impot Res 2010; 22: 325–335.Google Scholar
Singer, C, Weiner, WJ, Sanchez-Ramos, J. Autonomic dysfunction in men with Parkinson’s disease. Eur Neurol 1992; 32: 134–140.Google Scholar
Mobley, DF, Khera, M, Baum, N. Recent advances in the treatment of erectile dysfunction. Postgrad Med J 2017; 93: 679–685.CrossRefGoogle ScholarPubMed
Seidman, SN, Weiser, M. Testosterone and mood in aging men. Psychiatr Clin North Am 2013; 36: 177–182.Google Scholar
Ready, RE, Friedman, J, Grace, J, et al. Testosterone deficiency and apathy in Parkinson’s disease: a pilot study. J Neurol Neurosurg Psychiatry 2004; 75: 1323–1326.Google Scholar
Okun, MS, Fernandez, HH, Rodriguez, RL, et al. Testosterone therapy in men with Parkinson disease: results of the TEST-PD study. Arch Neurol 2006; 63: 729–735.Google Scholar
Porst, H, Montorsi, F, Rosen, RC, et al. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol 2007; 51: 816–823.CrossRefGoogle ScholarPubMed
Chuang, RS, Lang, AE. Rasagiline-induced spontaneous ejaculation. Mov Disord 2009; 24: 2160–2161.Google Scholar
Pohanka, M, Kanovsky, P, Bares, M, et al. Pergolide mesylate can improve sexual dysfunction in patients with Parkinson’s disease: the results of an open, prospective, 6-month follow-up. Eur J Neurol 2004; 11: 483–488.CrossRefGoogle ScholarPubMed
Grün, D, Pieri, V, Vaillant, M, et al. Contributory factors to caregiver burden in Parkinson disease. Am Med Dir Assoc 2016; 17: 626–632.Google Scholar
Bronner, G, Hassin-Baer, S. Exploring hypersexual behavior in men with Parkinson’s disease: is it compulsive sexual behavior? J Parkinsons Dis 2012; 2: 225–234.Google Scholar
Weintraub, D, Koester, J, Potenza, MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010; 67: 589–595.CrossRefGoogle ScholarPubMed
El Otmani, H, Mouni, FZ, Abdulhakeem, Z, et al. Impulse control disorders in Parkinson disease: a cross-sectional study in Morocco. Rev Neurol 2019; 175: 233–237.CrossRefGoogle ScholarPubMed
Moore, TJ, Glenmullen, J, Mattison, DR. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern Med 2014; 174: 1930–1933.CrossRefGoogle ScholarPubMed
Sachdeva, J, Harbishettar, V, Barraclough, M, et al. Clinical profile of compulsive sexual behaviors and paraphilia in Parkinson’s disease. J Parkinsons Dis 2014; 4: 665–670.CrossRefGoogle ScholarPubMed
Facelle, TM, Sadeghi-Nejad, H, Goldmeier, D. Persistent genital arousal disorder: characterization, etiology, and management. J Sex Med 2013; 10: 439–450.Google Scholar
Lefaucheur, R, Berthelot, L, Sénant, J, et al. Acute genital pain during non-motor fluctuations improved by apomorphine. Mov Disord 2013; 28: 687–688.CrossRefGoogle ScholarPubMed
Sawamura, M, Toma, K, Unai, Y, et al. A case of Parkinson’s disease following restless genital sensation. Rinsho Shinkeigaku 2015; 55: 266–268 [in Japanese].Google Scholar
Aquino, CC, Mestre, T, Lang, AE. Restless genital syndrome in Parkinson disease. JAMA Neurol 2014; 71: 1559–1561.Google Scholar
Fountoulakis, KN, Tegos, T, Goulis, DG, et al. Treatment of a female patient with persistent genital arousal and Parkinson’s disease with paliperidone. Aust N Z J Psychiatry 2017; 51: 98–99.Google Scholar
Meco, G, Rubino, A, Caravona, N, et al. Sexual dysfunction in Parkinson’s Disease. Parkinsonism Relat Disord 2008; 14: 451–456.CrossRefGoogle ScholarPubMed
Hatzimouratidis, K, Amar, E, Eardley, I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010; 57: 804–814.Google Scholar
Serretti, A, Chiesa, A. Sexual side effects of pharmacological treatment of psychiatric diseases. Clin Pharmacol Ther 2011; 89: 142–147.Google Scholar
Connolly, BS, Lang, AE. Pharmacological treatment of Parkinson disease: a review. JAMA 2014; 311: 1670–1683.Google Scholar
Paredes, RG, Agmo, A. Has dopamine a physiological role in the control of sexual behavior? A critical review of the evidence. Prog Neurobiol 2004; 73: 179–226.Google Scholar
Kruger, TH, Hartmann, U, Schedlowski, M. Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans. World J Urol 2005; 23: 130–138.Google Scholar
Kaut, O, Asmus, F, Paus, S. Spontaneous unwelcome orgasms due to pramipexole and ropinirole. Mov Disord 2012; 27: 1327–1328.CrossRefGoogle ScholarPubMed
Kataoka, H, Sugie, K. Delusional jealousy (Othello Syndrome) in 67 patients with Parkinson’s disease. Front Neurol 2018; 9: 129.Google Scholar
Dulski, J, Schinwelski, M, Konkel, A, et al. The impact of subthalamic deep brain stimulation on sleep and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 2019; 64: 138–144.Google Scholar
Castelli, L, Perozzo, P, Genesia, ML, et al. Sexual well-being in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. J Neurol Neurosurg Psychiatry 2004; 75: 1260–1264.Google Scholar
Merola, A, Romagnolo, A, Rizzi, L, et al. Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease. J Neurol 2017; 264: 40–48.Google Scholar
Romito, LM, Raja, M, Daniele, A, et al. Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson’s disease. Mov Disord 2002; 17: 1371–1374.CrossRefGoogle ScholarPubMed
Doshi, P, Bhargava, P. Hypersexuality following subthalamic nucleus stimulation for Parkinson’s disease. Neurol India 2008; 56: 474–476.Google Scholar
Standaert, DG, Rodriguez, RL, Slevin, JT, et al. Effect of levodopa‐carbidopa intestinal gel on non‐motor symptoms in patients with advanced Parkinson’s disease. Mov Disord Clin Pract 2017; 4: 829–837.Google Scholar
Drapier, S, Eusebio, A, Degos, B, et al. Quality of life in Parkinson’s disease improved by apomorphine pump: the OPTIPUMP cohort study. J Neurol 2016; 263: 1111–1119.Google Scholar
Jenner, P, Katzenschlager, R. Apomorphine – pharmacological properties and clinical trials in Parkinson’s disease. Parkinsonism Relat Disord 2016; 33(Suppl 1): S13–S21.CrossRefGoogle ScholarPubMed
Dula, E, Keating, W, Siami, PF, et al. Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group. Urol 2000; 56: 130–135.Google ScholarPubMed
Perimenis, P, Markou, S, Gyftopoulos, K, et al. Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study. Andrologia 2004; 36: 106–110.Google Scholar
Colzi, A, Turner, K, Lees, A. Continuous subcutaneous waking day apomorphine in the long-term treatment of levodopa induced interdose dyskinesias in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1998; 64: 573–576.Google Scholar
Bowron, A. Practical considerations in the use of apomorphine injectable. Neurology 2004; 62(6 Suppl 4): S32–S36.Google Scholar
Barbosa, P, Lees, AJ, Magee, C, et al. A retrospective evaluation of the frequency of impulsive compulsive behaviors in Parkinson’s disease patients treated with continuous waking day apomorphine pumps. Mov Disord Clin Pract 2016; 4: 323–328.Google Scholar
Jiann, BP, Su, CC, Tsai, JY. Is female sexual function related to the male partners’ erectile function? J Sex Med 2013; 10: 420–429.Google Scholar
Elran, E, Bronner, G, Uziel, N, et al. The impact of vaginal penetration difficulties on the sexual functioning of women and their male partners. Eur J Contracept Reprod Health Care 2014; 19: 352–358.CrossRefGoogle ScholarPubMed
Wielinski, CL, Varpness, SC, Erickson-Davis, C, et al. Sexual and relationship satisfaction among persons with young-onset Parkinson’s disease. J Sex Med 2010; 7(4 Pt 1): 1438–1444.Google Scholar
Yu, M, Roane, DM, Miner, CR, et al. Dimensions of sexual dysfunction in Parkinson disease. Am J Geriatr Psychiatry 2004; 12: 221–226.Google Scholar
Stevenson, RWD. Sexual medicine: why psychiatrists must talk to their patients about sex. Can J Psychiatry 2004; 49: 673–677.Google Scholar
Rutte, A, van Oppen, P, Nijpels, G, et al. Effectiveness of a PLISSIT model intervention in patients with type 2 diabetes mellitus in primary care: design of a cluster-randomised controlled trial. BMC Fam Pract 2015; 16: 69.Google Scholar
Basson, R, Bronner, G. Management and rehabilitation of neurologic patients with sexual dysfunction. Handb Clin Neurol 2015; 130: 415–434.Google Scholar
Bronner, G. Practical strategies for the management of sexual problems in Parkinson’s disease. Parkinsonism Relat Disord 2009; 15(Suppl 3): S96–S100.CrossRefGoogle ScholarPubMed
Dyer, K, das Nair, R. Why don’t healthcare professionals talk about sex? A systematic review of recent qualitative studies conducted in the United Kingdom. J Sex Med 2013; 10: 2658–2670.Google Scholar
Bronner, G, Gurevich, T. Management of neurogenic sexual dysfunction. In: Nair, KPS, Gonzalez-Fernandez, M, Panicker, JN, (eds.). Neurorehabilitation Therapy and Therapeutics. Cambridge University Press; 2019, 224–235.Google Scholar
Zesiewicz, TA, Helal, M, Hauser, RA. Sildenafil citrate (viagra) for the treatment of erectile dysfunction in men with Parkinson’s disease. Mov Disord 2000; 15: 305–308.Google Scholar
Pfeiffer, RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol 2003; 2: 107–116.Google Scholar
Costa, P, Potempa, AJ. Intraurethral alprostadil for erectile dysfunction: a review of the literature. Drugs 2012; 72: 2243–2254.Google Scholar
Rocinante, M. Living with autonomic failure. Clin Auton Res 2008; 18: 48–51.Google Scholar
Allahdadi, KJ, Tostes, RC, Webb, RC. Female sexual dysfunction: therapeutic options and experimental challenges. Cardiovasc Hematol Agents Med Chem 2009; 7: 260–269.CrossRefGoogle ScholarPubMed
Catalan, MJ, De Pablo-Fernandez, E, Villanueva, C, et al. Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson’s disease. Mov Disord 2013; 28: 2007–2010.Google Scholar
Bronner, G, Korczyn, AD. The role of sex therapy in the management of Parkinson’s disease patients. Mov Disord Clin Pract 2018; 5: 6–13.Google Scholar
Lafortune, D, Dion, L, Renaud, P. Virtual reality and sex therapy: future directions for clinical research. J Sex Marital Ther 2019; 4: 1–17.Google Scholar
Maples-Keller, JL, Bunnell, BE, Kim, SJ, et al. The use of virtual reality technology in the treatment of anxiety and other psychiatric disorders. Harv Rev Psychiatry 2017; 25: 103–113.CrossRefGoogle ScholarPubMed
Iruthayarajah, J, McIntyre, A, Cotoi, A, et al. The use of virtual reality for balance among individuals with chronic stroke: a systematic review and meta-analysis. Top Stroke Rehabil 2017; 24: 68–79.Google Scholar
Spiegel, B, Fuller, G, Lopez, M, et al. Virtual reality for management of pain in hospitalized patients: a randomized comparative effectiveness trial. PLoS One 2019; 14: e0219115.Google Scholar
Manera, V, Ben-Sadoun, G, Aalbers, T, et al. Recommendations for the use of serious games in neurodegenerative disorders: 2016 Delphi Panel. Front Psychol 2017; 8: 1243.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×